UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology.
Looking for a particular UNITY Biotechnology employee's phone or email?
The UNITY Biotechnology annual revenue was $1 million in 2026.
Anirvan Ghosh is the CEO of UNITY Biotechnology.
27 people are employed at UNITY Biotechnology.
UNITY Biotechnology is based in South San Francisco, California.
The NAICS codes for UNITY Biotechnology are [54171, 54, 5417, 541, 541711, 541712].
The SIC codes for UNITY Biotechnology are [873, 87].